Lansforsakringar Fondforvaltning’s Bristol-Myers Squibb BMY Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.4M	Sell	631,068 -28,008	-4%	-$1.61M	0.16%	113
2026 Q1	$40M	Sell	659,076 -104,772	-14%	-$6.11M	0.21%	90
2025 Q4	$41.2M	Buy	763,848 +6,611	+0.9%	+$318K	0.2%	97
2025 Q3	$34.2M	Buy	757,237 +16,240	+2%	+$758K	0.18%	104
2025 Q2	$34.3M	Sell	740,997 -28,407	-4%	-$1.39M	0.2%	92
2025 Q1	$46.9M	Sell	769,404 -888	-0.1%	-$51.8K	0.29%	72
2024 Q4	$43.6M	Buy	+770,292	New	+$43M	0.24%	81

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lansforsakringar Fondforvaltning's BMY Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q2 2026, selling an estimated $1.61M and leaving 631,068 shares worth $36.4M. The position accounts for 0.16% of the portfolio, ranked #113.

Lansforsakringar Fondforvaltning first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $46.9M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Lansforsakringar Fondforvaltning held 631,068 shares of Bristol-Myers Squibb worth $36.4M as of Q2 2026.
Lansforsakringar Fondforvaltning sold 28,008 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.61M.
Bristol-Myers Squibb made up 0.16% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #113 holding.
Lansforsakringar Fondforvaltning first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Lansforsakringar Fondforvaltning's Bristol-Myers Squibb position peaked at $46.9M in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.